FDA
-
-
-
-
-
-
-
H.C. Wainwright Downgrades CalciMedica (CALC) to Neutral
-
-
-
-
-
-
-
CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
-
-
-
-
-
-
-
CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxoraâ„¢ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG)
-
-
-
-
-
-
-
CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
-
-
-
-
-
323,995 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

